Contribution: Industrial Research Assistance Program – Contributions to Firms
Alectos Therapeutics Inc.
$200,000.00
Discovery and Preclinical Development of Novel Compounds for Niemann-Pick Type C Disease
EF 2018-19 · 2018-07-01
Résumé
Novel targeted small molecule modulators will be designed, tested and characterized as disease-modifying therapeutics for Niemann-Pick Type C disease.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Burnaby|Burnaby, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
851456152
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2019-06-30
Agreement Number
910465
Agreement Start Date
2018-07-01
Agreement Title
Discovery and Preclinical Development of Novel Compounds for Niemann-Pick Type C Disease
Agreement Title (French)
Développement de découverte et préclinique de nouveaux composés pour la maladie de Niemann-Pick Type C
Agreement Type
Contribution
Agreement Value
$200,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Novel targeted small molecule modulators will be designed, tested and characterized as disease-modifying therapeutics for Niemann-Pick Type C disease.
Description (French)
De nouveaux modulateurs à petites molécules ciblés seront conçus, testés et caractérisés comme agents thérapeutiques modifiant la maladie de Niemann-Pick de type C.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Burnaby North--Seymour
Federal Riding (French)
Burnaby-Nord--Seymour
Federal Riding Number
59002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
851456152
Recipient City
Burnaby|Burnaby
Recipient Country
CA
Recipient Legal Name
Alectos Therapeutics Inc.
Recipient Postal Code
V5A 4B5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q2-910465
